)
Visual
earnings real time
Genedrive (GDR) investor relations material
Genedrive H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary8 Dec, 2025
Executive summary
Provides rapid pharmacogenetic testing for emergency healthcare, with two CE-IVD-certified products addressing antibiotic-induced hearing loss in neonates and clopidogrel resistance in stroke/cardiovascular patients, co-developed with NHS partners.
Both products are recommended by NICE, have strong clinical guidance, and are in routine clinical use in early adopter hospitals, showing early commercial traction in the UK and internationally.
Company operates a capital-light, outsourced manufacturing model, supporting scalability and recurring revenue.
Financial highlights
FY25 total income reached GBP 1 million, up from GBP 50k in 2023 and GBP 501k in FY24, with revenue from customer contracts at GBP 764k.
Loss before tax improved to GBP 5.4 million from GBP 7.8 million in FY24, while operating loss for FY25 was GBP 5.38 million.
Net cash outflow for the year was GBP 4 million, with cash at end of FY25 at GBP 1.18 million, down from GBP 5.19 million at the start of the year.
Monthly cash burn reduced to GBP 350,000 in the current year, with an average of GBP 468,000 in FY25.
Equity investment of GBP 1.23 million received in April 2025.
Outlook and guidance
Well positioned to capitalize on growing demand for near-patient pharmacogenetic testing in emergency care, with no direct competitors offering equivalent solutions.
Ongoing phased implementation in Scotland and pilot programs in Saudi Arabia, with potential for national rollouts.
Regulatory submissions for U.S. market on track, with CYP2C19 510(k) submission expected late Q4 FY26 and MT-RNR1 de novo submission targeted for end of 2026.
Recurring revenue potential with expanding domestic and international commercial traction.
Long-term capital funding strategy
Address ICB commissioning challenges
US market entry strategy for both products
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Genedrive earnings date
H1 202626 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage